COVID-19 - Updates Archives

April 21, 2022

Answering the Most Common Questions About COVID-19 Booster Doses and Evusheld for Those with CLL/SLL

CLL Society has been receiving multiple questions surrounding Evusheld and the newly recommended second booster dose (fifth dose in total) for all individuals who are immunocompromised. These new recommendations are applicable to everyone with CLL/SLL.

April 21, 2022

COVID-19 Vaccine Refusal and Fair Allocation of Scarce Medical Resources: Moving CLL/SLL and Other Immunocompromised Patients to the Top Tier

In a pandemic with scarce resources, governments, medical institutions, and healthcare providers have had to make decisions and/or policies about allocating potentially lifesaving therapies among the many outpatients who might benefit from them.

April 21, 2022

ASH 2021: Dr. Larry A. Saltzman Discusses SARS-Cov-2 Antibody Levels in Blood Cancer Patients after a Third Sars-Cov-2 “Booster” Vaccination

At the annual meeting of the American Society of Hematology (ASH) 2021, Dr. Brian Koffman interviewed Dr. Larry Saltzman, a Family Physician and Executive Research Director of the Leukemia and Lymphoma Society. They discussed the benefits of a “booster” vaccine dose for blood cancer patients.

April 8, 2022

The Most Recent COVID-19 Vaccination Schedule for CLL/SLL Patients

CLL/SLL patients are being refused Evusheld while tens of thousands of unused doses are even expiring.

March 29, 2022

Pre- and Post-Exposure Options for CLL Patients COVID-19 Omicron Variant

CLL Society support group’s facilitator, Jim Werner PhD, MSSA, of Case Western Reserve University in Cleveland, Ohio, put together this update on COVID-19 in January 2022.

March 25, 2022

The CLL Nurse’s Note: Nine Items to Have at Home for COVID-19

In addition to having the COVID-19 Action Plan complete, it is encouraged to prepare for isolation by gathering a two-week supply of the following items:

March 25, 2022

Vulnerable Americans are Desperate to Find this COVID-19 drug. Thousands of Boxes are Sitting Around Unused

We are going through a needless tragedy that will only worsen since Congress elected not to fund any more Evusheld. As a result, the already inadequate supplies will dwindle even more.

March 21, 2022

It Was Already Hard to Find Evusheld, a COVID-19 Prevention Therapy. Now It’s Even Harder.

CLL Society is working to right the ship, but in the meantime, if you are considering getting Evusheld, it makes sense to not delay. Not that you need to panic. There are many thousands of doses out there now and more coming, albeit at a slower rate. But the

March 21, 2022

Lifesaving COVID Drugs Are Sitting Unused on Pharmacy Shelves

CLL/SLL patients are being refused Evusheld while tens of thousands of unused doses are even expiring.

COVID-19 – Updates

Answering the Most Common Questions About COVID-19 Booster Doses and Evusheld for Those with CLL/SLL

COVID-19 Vaccine Refusal and Fair Allocation of Scarce Medical Resources: Moving CLL/SLL and Other Immunocompromised Patients to the Top Tier

ASH 2021: Dr. Larry A. Saltzman Discusses SARS-Cov-2 Antibody Levels in Blood Cancer Patients after a Third Sars-Cov-2 “Booster” Vaccination

The Most Recent COVID-19 Vaccination Schedule for CLL/SLL Patients

Pre- and Post-Exposure Options for CLL Patients COVID-19 Omicron Variant

The CLL Nurse’s Note: Nine Items to Have at Home for COVID-19

Vulnerable Americans are Desperate to Find this COVID-19 drug. Thousands of Boxes are Sitting Around Unused

It Was Already Hard to Find Evusheld, a COVID-19 Prevention Therapy. Now It’s Even Harder.

Lifesaving COVID Drugs Are Sitting Unused on Pharmacy Shelves

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT US

CONTACT